Cholesterol Trafficking: An Emerging Therapeutic Target for Angiogenesis and Cancer

Cells. 2019 Apr 28;8(5):389. doi: 10.3390/cells8050389.

Abstract

Cholesterol is an essential structural component of cellular membranes. In addition to the structural role, it also serves as a precursor to a variety of steroid hormones and has diverse functions in intracellular signal transduction. As one of its functions in cell signaling, recent evidence suggests that cholesterol plays a key role in regulating angiogenesis. This review discusses the role of cholesterol in angiogenesis, with a particular emphasis on cholesterol trafficking in endothelial cell signaling. Small molecule inhibitors of cholesterol trafficking and their preclinical and clinical development targeting angiogenesis and cancer are also discussed.

Keywords: NPC1; angiogenesis; cholesterol trafficking; lysosome; mTOR.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Angiogenesis Inhibitors / pharmacology*
  • Animals
  • Biological Transport / drug effects
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Cholesterol / physiology*
  • Endothelial Cells* / cytology
  • Endothelial Cells* / drug effects
  • Endothelial Cells* / pathology
  • Humans
  • Neoplasms* / drug therapy
  • Neoplasms* / metabolism
  • Neovascularization, Pathologic* / drug therapy
  • Neovascularization, Pathologic* / metabolism
  • Signal Transduction / drug effects

Substances

  • Angiogenesis Inhibitors
  • Cholesterol